{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:43:12Z","timestamp":1778222592578,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neuropeptidesjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.npep.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T12:15:01Z","timestamp":1410869701000},"page":"335-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice"],"prefix":"10.1016","volume":"48","author":[{"given":"S.H.","family":"Christiansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V.","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"G\u00f8tzsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.P.D.","family":"Woldbye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2014.09.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001079","article-title":"Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens","volume":"2","author":"Alexander","year":"2010","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.npep.2014.09.004_bib0015","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1523\/JNEUROSCI.1246-08.2008","article-title":"Contextual fear conditioning in humans: cortical-hippocampal and amygdala contributions","volume":"28","author":"Alvarez","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1016\/j.npep.2014.09.004_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00124509-199903000-00008","article-title":"Electroconvulsive therapy as an anticonvulsant: a possible role of neuropeptide Y (NPY)","volume":"15","author":"Bolwig","year":"1999","journal-title":"J. ECT"},{"key":"10.1016\/j.npep.2014.09.004_bib0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0169-328X(98)00137-5","article-title":"Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment","volume":"59","author":"Caberlotto","year":"1998","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jnr.21028","article-title":"Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice","volume":"84","author":"Christensen","year":"2006","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0035","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1002\/jnr.22517","article-title":"Regulation of the galanin system by repeated electroconvulsive seizures in mice","volume":"88","author":"Christiansen","year":"2010","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbr.2010.08.044","article-title":"Fluoxetine reverts chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice","volume":"216","author":"Christiansen","year":"2011","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modeling human depression and anxiety","volume":"4","author":"Cryan","year":"2005","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.npep.2014.09.004_bib0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev"},{"key":"10.1016\/j.npep.2014.09.004_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2009.12.088","article-title":"Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: behavioral and immunocytochemical evidences","volume":"1318","author":"Deo","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0060","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neuron.2013.06.016","article-title":"BLA to vHPC inputs modulate anxiety-related behaviors","volume":"79","author":"Felix-Ortiz","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2014.09.004_bib0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-009-1610-8","article-title":"Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect","volume":"206","author":"Fendt","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.npep.2014.09.004_bib0070","first-page":"23","article-title":"Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls","volume":"17","author":"Gjerris","year":"1992","journal-title":"J. Psychiatry Neurosci"},{"key":"10.1016\/j.npep.2014.09.004_bib0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.nbd.2011.08.012","article-title":"Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures","volume":"45","author":"G\u00f8tzsche","year":"2012","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.npep.2014.09.004_bib0080","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1523\/JNEUROSCI.2305-08.2008","article-title":"The role of neuropeptide Y in the expression and extinction of fear-potentiated startle","volume":"28","author":"Gutman","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1016\/j.npep.2014.09.004_bib0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0165-3806(92)90257-W","article-title":"Kindling in developing animals: interactions between ipsilateral loci","volume":"68","author":"Haas","year":"1992","journal-title":"Brain Res. Dev. Brain Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2014.09.004_bib0095","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.npep.2014.09.004_bib0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.1993.35","article-title":"Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects","volume":"8","author":"Heilig","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2014.09.004_bib0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3956(03)00101-8","article-title":"Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar depression: preliminary evidence for association with preproNPY gene polymorphism","volume":"38","author":"Heilig","year":"2004","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/mt.2009.175","article-title":"Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease","volume":"18","author":"Hudry","year":"2010","journal-title":"Mol. Ther"},{"key":"10.1016\/j.npep.2014.09.004_bib0115","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0028-3908(00)00009-5","article-title":"Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram","volume":"39","author":"Husum","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2014.09.004_bib0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0893-133X(00)00198-6","article-title":"Changed concentrations of tachykinins and neuropeptide Y in brain of a rat model of depression: lithium treatment normalizes tachykinins","volume":"24","author":"Husum","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2014.09.004_bib0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hipo.20264","article-title":"Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor","volume":"17","author":"Ishida","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.npep.2014.09.004_bib0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0022-3956(00)00036-4","article-title":"Neuropeptide Y in male and female brains of Flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli","volume":"34","author":"Jim\u00e9nez-Vasquez","year":"2000","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0135","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.npep.2014.09.004_bib0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1460-9568.2008.06306.x","article-title":"Behavioural profile of a new mouse model for NPY deficiency","volume":"28","author":"Karl","year":"2008","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.npep.2014.09.004_bib0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1601-5215.2011.00600.x","article-title":"Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression","volume":"24","author":"Koefoed","year":"2012","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.npep.2014.09.004_bib0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2013.10.014","article-title":"Role of neuropeptides in anxiety, stress, and depression: from animals to humans","volume":"47","author":"Kormos","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2014.09.004_bib0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.peptides.2004.01.005","article-title":"Our journey with neuropeptide Y: effects on ingestive behaviors and energy expenditure","volume":"25","author":"Levine","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2014.09.004_bib0160","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/BF02977341","article-title":"Stimulative and sedative effects of essential oils upon inhalation in mice","volume":"28","author":"Lim","year":"2005","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0165","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1210\/en.2006-0097","article-title":"Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity","volume":"147","author":"Lin","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2014.09.004_bib0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1528-1167.2006.00500.x","article-title":"Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice","volume":"47","author":"Lin","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2014.09.004_bib0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.euroneuro.2009.08.004","article-title":"Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice","volume":"20","author":"Lin","year":"2010","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.npep.2014.09.004_bib0180","first-page":"204","article-title":"Development of gene therapy for neurological disorders","volume":"9","author":"Manfredsson","year":"2010","journal-title":"Discov. Med"},{"key":"10.1016\/j.npep.2014.09.004_bib0185","series-title":"The Mouse Nervous System","article-title":"Piriform cortex and amygdala","author":"Mart\u00ednez-Garc\u00eda","year":"2012"},{"key":"10.1016\/j.npep.2014.09.004_bib0190","first-page":"60","article-title":"Neuropeptides and electroconvulsive treatment","volume":"15","author":"Mathe","year":"1999","journal-title":"J. ECT"},{"key":"10.1016\/j.npep.2014.09.004_bib0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1358\/dnp.2010.23.5.1468393","article-title":"The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy","volume":"23","author":"McCown","year":"2010","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.npep.2014.09.004_bib0200","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1038\/tp.2013.31","article-title":"Allele-specific programming of NPY and epigenetic effects of physical activity in a genetic model of depression","volume":"3","author":"Melas","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.npep.2014.09.004_bib0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/archgenpsychiatry.2010.197","article-title":"Emotion processing, major depression, and functional genetic variation of neuropeptide Y","volume":"68","author":"Mickey","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.npep.2014.09.004_bib0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jpsychires.2005.02.005","article-title":"Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation","volume":"40","author":"Mikkelsen","year":"2006","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0169-328X(94)90241-0","article-title":"Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus","volume":"23","author":"Mikkelsen","year":"1994","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0220","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1517\/14712598.2010.509341","article-title":"Gene therapy in rodent amygdala against fear disorders","volume":"10","author":"Mitra","year":"2010","journal-title":"Expert Opin. Biol. Ther"},{"key":"10.1016\/j.npep.2014.09.004_bib0225","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0230","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2011.06.030","article-title":"Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety","volume":"62","author":"Morales-Medina","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2014.09.004_bib0235","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.eurpsy.2008.03.003","article-title":"CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy","volume":"23","author":"Nikisch","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.npep.2014.09.004_bib0240","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S1461145705005158","article-title":"Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram","volume":"8","author":"Nikisch","year":"2005","journal-title":"Int. J. Neuropsychopharmacol"},{"key":"10.1016\/j.npep.2014.09.004_bib0245","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jnr.22770","article-title":"Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice","volume":"90","author":"Olesen","year":"2012","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.npep.2012.01.002","article-title":"Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity","volume":"46","author":"Olesen","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2014.09.004_bib0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-61779-458-2_7","article-title":"Modeling depression in animal models","volume":"829","author":"Overstreet","year":"2012","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.npep.2014.09.004_bib0260","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1601-183X.2008.00389.x","article-title":"Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice","volume":"7","author":"Painsipp","year":"2008","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.npep.2014.09.004_bib0265","series-title":"The Mouse Brain \u2013 in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.npep.2014.09.004_bib0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.2000.tb06738.x","article-title":"Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat: a review","volume":"911","author":"Pitk\u00e4nen","year":"2000","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.npep.2014.09.004_bib0275","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther"},{"key":"10.1016\/j.npep.2014.09.004_bib0280","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.npp.1300705","article-title":"Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors","volume":"30","author":"Primeaux","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2014.09.004_bib0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2014.09.004_bib0290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2008.01743.x","article-title":"Gene therapy in epilepsy","volume":"50","author":"Riban","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.npep.2014.09.004_bib0295","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.4056-03.2004","article-title":"Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus","volume":"24","author":"Richichi","year":"2004","journal-title":"J. Neurosci"},{"key":"10.1016\/j.npep.2014.09.004_bib0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(99)00018-7","article-title":"Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test","volume":"368","author":"Sajdyk","year":"1999","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.npep.2014.09.004_bib0305","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0028-3908(02)00234-4","article-title":"Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats","volume":"43","author":"Sajdyk","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2014.09.004_bib0310","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(01)00679-7","article-title":"Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala","volume":"71","author":"Sajdyk","year":"2002","journal-title":"Pharmacol. Biochem. Behav"},{"key":"10.1016\/j.npep.2014.09.004_bib0315","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0014-2999(91)90896-X","article-title":"Anti-sedative and anti-cataleptic properties of NCS-382, a [gamma]-hydroxybutyrate receptor antagonist","volume":"203","author":"Schmidt","year":"1991","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.npep.2014.09.004_bib0320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00213-011-2225-4","article-title":"Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice","volume":"216","author":"Schmidt","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.npep.2014.09.004_bib0325","doi-asserted-by":"crossref","first-page":"e5865","DOI":"10.1371\/journal.pone.0005865","article-title":"Human fear conditioning and extinction in neuroimaging: a systematic review","volume":"4","author":"Sehlmeyer","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.npep.2014.09.004_bib0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.npep.2005.06.002","article-title":"Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior","volume":"39","author":"Slawecki","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2014.09.004_bib0335","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.expneurol.2008.10.015","article-title":"Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP","volume":"215","author":"S\u00f8rensen","year":"2009","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.npep.2014.09.004_bib0340","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20200","article-title":"Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation","volume":"77","author":"S\u00f8rensen","year":"2004","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0345","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jnr.490240315","article-title":"Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain","volume":"24","author":"Stenfors","year":"1989","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.npep.2014.09.004_bib0355","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.npep.2014.09.004_bib0360","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1523\/JNEUROSCI.0430-10.2010","article-title":"The central and basolateral amygdala are critical sites of neuropeptide Y\/Y2 receptor-mediated regulation of anxiety and depression","volume":"30","author":"Tasan","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1016\/j.npep.2014.09.004_bib0365","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1073\/pnas.220232997","article-title":"Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression","volume":"97","author":"Thorsell","year":"2000","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"10.1016\/j.npep.2014.09.004_bib0370","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/brain\/awm033","article-title":"Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats","volume":"130","author":"Thorsell","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.npep.2014.09.004_bib0375","doi-asserted-by":"crossref","first-page":"14139","DOI":"10.1523\/JNEUROSCI.3280-07.2007","article-title":"Differential effects of recombinant adeno-associated virus-mediated neuropeptide Y overexpression in the hypothalamic paraventricular nucleus and lateral hypothalamus on feeding behavior","volume":"27","author":"Tiesjema","year":"2007","journal-title":"J. Neurosci"},{"key":"10.1016\/j.npep.2014.09.004_bib0380","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1476-5381.2012.01872.x","article-title":"NPY controls fear conditioning and fear extinction by combined action on Y1 and Y2 receptors","volume":"166","author":"Verma","year":"2012","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.npep.2014.09.004_bib0385","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(90)90523-E","article-title":"Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat","volume":"507","author":"Wahlestedt","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0390","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-3956(88)90030-1","article-title":"Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively","volume":"22","author":"Widerl\u00f6v","year":"1988","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.npep.2014.09.004_bib0395","series-title":"The Mouse Nervous System","article-title":"Hippocampus","author":"Witter","year":"2012"},{"key":"10.1016\/j.npep.2014.09.004_bib0400","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/brain\/awq219","article-title":"Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures","volume":"133","author":"Woldbye","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.npep.2014.09.004_bib0405","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14728222.2011.628314","article-title":"Central functions of neuropeptide Y in mood and anxiety disorders","volume":"15","author":"Wu","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.npep.2014.09.004_bib0410","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1152\/physiolgenomics.00082.2009","article-title":"Changes in behavior and gene expression induced by caloric restriction in C57BL\/6 mice","volume":"39","author":"Yamamoto","year":"2009","journal-title":"Physiol. Genomics"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341791400081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341791400081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T19:25:12Z","timestamp":1538249112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014341791400081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S014341791400081X"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2014.09.004","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiolytic-like effects after vector-mediated overexpression of neuropeptide Y in the amygdala and hippocampus of mice","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}